TAMPA, Fla.–(BUSINESS WIRE)–industryGENOME, a cutting-edge analytics firm specializing in granular precision insights, has released its first-ever Clinical Trial Patient Access Organization (PAO) Market Map Report, developed in collaboration with WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, and Crosstree. This report offers an unparalleled bottom-up analysis of the PAO sector, using AI-powered classification models to predict private company revenue and stratify market estimates across geographies, subsidiaries, and specialized capabilities.
Transforming Industry Analysis with AI-Assisted Precision
Leveraging its proprietary Industry Capabilities Classification System (ICCS®), industryGENOME provides a standardized and globally applicable framework for categorizing businesses. The ICCS® methodology enhances financial analysis, investment decision-making, and strategy development across the life sciences and healthcare industries.
The report was developed in close collaboration with WCG, which played a pivotal role in identifying global industry participants to ensure the most comprehensive market representation. Crosstree assisted industryGENOME in industry classification quality assurance and predictive modeling, enhancing the precision of market insights.
“This report is the most sophisticated analysis of the clinical trial PAO sector to date,” said Shane Senior, Managing Director at Crosstree. “industryGENOME’s AI-driven predictive engines achieve 85% classification accuracy, surpassing human classifiers, and ensuring the most precise industry intelligence for investors and market participants. The ability to scale this precision across large data sets is unprecedented.”
Key Findings from the Clinical Trial PAO Market Map Report
- Total Market Revenue: $14.95 billion
- Industry Participants: Over 3,000 global Patient Access Organizations with detailed company profiles for each
- Industry Stratification: Freestanding, Mobile, Virtual, Provider Embedded, and Service Embedded Sites
- Top Industry Players: Velocity, IQVIA, PPD, AES, CenExel Clinical Research, ERG, Javara
- Advanced Market Mapping: AI-assisted data collection and synthesis for high-fidelity revenue estimates allowing for “sum-of-the-parts” bottom-up market sizing
- Geo-Stratification Analysis: The United States leads with $10.6 billion in revenue, followed by the UK, Germany, and Australia
Why This Report Sets a New Standard
industryGENOME’s bottom-up methodology, empowered by machine learning and predictive analytics, provides unprecedented insights into the PAO sector. The firm’s mapped markets process, which identifies, collects, and analyzes micro-industry data, ensures highly precise revenue estimates, critical for investors, procurement specialists, and drug developers seeking strategic market positioning.
Access the Report Today
To access the Clinical Trial PAO Market Map Report, visit industryGENOME.com or contact Jordan Schiding at Jordan.Schiding@industryGENOME.com.
About industryGENOME
industryGENOME is a market intelligence platform for the Health Sciences industry that continuously collects and analyzes millions of data points on pharma services companies, investors, deals, valuations, research, conferences, and news. It produces bottom-up market research reports and company profiles by combining AI with the expertise of industry investment professionals.
The platform is distinguished by a proprietary, highly granular taxonomy that categorizes industry participant capabilities through defined relationships. This classification system delivers clean, precise, and actionable insights on the Health Sciences market.
Using AI technologies—including natural language processing, machine translation, and supervised machine learning—industryGENOME classifies and curates data. In partnership with Crosstree, the platform trains its classification algorithm for accuracy and precision. Together, they are mapping the Health Sciences market one company at a time to deliver detailed, bottom-up industry segment insights. Learn more at industryGENOME.com.
About Crosstree
Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree’s narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion.
About WCG
WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit wcgclinical.com or follow us on LinkedIn or X @WCGClinical.
Contacts
industryGENOME and Crosstree Media Contact:
Hillary McCutcheon
Freshwater Marketing
813.992.1470
hillary@freshwater-marketing.com
WCG Media Contact:
Carmin Gade, PhD
Chief Marketing Officer, WCG
484.351.9959
cgade@wcgclinical.com
